Senior Director, Commercial Forecasting & Artificial Intelligence

Scorpion Therapeutics; United States; Remote; USD 180,000 - 280,000; Full time

Job summary

Immatics is seeking a Senior Director of Commercial Forecasting & AI to lead forecasting across the oncology portfolio and drive AI-enabled improvements in demand, revenue, and patient flow.

You will build models from early pipeline through post-launch and partner with cross-functional teams to implement AI-driven analytics in regulated environments, while overseeing vendor evaluations and platform selection.

Qualifications

• 15+ years in life sciences with forecasting, commercial analytics, or market insights.
• Experience building patient-based models, especially oncology, cell/gene therapies, or rare diseases.
• Strong knowledge of pharma/biotech data sources; hands-on AI in regulated environments.
• Proficiency in Excel, Python, SQL, Power BI or Tableau.

Responsibilities

• Develop forecasting models from early pipeline to post-launch.
• Partner with Marketing, Market Access, Medical Affairs cross-functionally.
• Design AI-driven systems for automated data ingestion and analytics.
• Evaluate AI vendors and platforms.

Skills

Forecasting

Commercial analytics

Market insights

AI in pharma

Tools

Excel

Python

SQL

Power BI/Tableau

Job description

Role: Senior Director, Commercial Forecasting & AI at Immatics, leading demand, revenue, and patient-flow forecasting across the oncology portfolio while pioneering AI and generative-AI capabilities to enhance commercial team performance.

Responsibilities

Developing forecasting models from early pipeline to post-launch, partnering with cross-functional teams (Marketing, Market Access, Medical Affairs), designing AI-driven systems for automated data ingestion and analytics, and evaluating AI vendors and platforms.

Requirements

15+ years in life sciences with expertise in forecasting, commercial analytics, or market insights; proven experience building patient-based models, especially in oncology, cell and gene therapies, or rare diseases; strong knowledge of pharma/biotech data sources; hands-on AI application experience in regulated environments; advanced proficiency in Excel, Python, SQL, Power BI/Tableau.

Preferred

Background in launching autologous cell therapies, experience with global forecasting, and familiarity with market access analytics.

High-value specifics

Oncology, cell/gene therapy, pre-launch and in-line asset forecasting, regulated AI use, and global market considerations.

Work setup

Remote U.S.; travel approximately 10-15%.